<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210104049939N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-01</date_registration>
      <primary_sponsor>Najaf Abadَ Islamic Azad  University</primary_sponsor>
      <public_title>Comparison of the effect of 12 weeks of aerobic and combined training based on performance indicators and some other cardiovascular risk factors affected by amputation</public_title>
      <acronym>ectc</acronym>
      <scientific_title>The Comparison of Eeffect of Aerobic and Combined Exercise Training on Functional Indicators and some cardiovascular risk factors in lower-limb amputee</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-03-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53494</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Factorial, Purpose: Prevention, Randomization description: After the announcement of the call and examination of the medical files, the candidates are enrolled in the study, and after the examination, based on the criteria of entry and exit from the study, 45 veterans of lower body amputations are selected as a sample. 45 samples are selected through available sampling and randomly divided into one of 3 groups: aerobic training (15 people), combined training (15 people) and control (15 people). Randomization is done by block method and by an assistant outside the research. In this way, the samples are randomized in the form of 3:3:3 blocks in each of the studied groups, Blinding description: The subjects are blinded to the grouping and the training sessions of the groups are done on different days.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Lower limb amputation veterans.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Aerobic exercise: Aerobic group exercises include 12 weeks of exercises, 3 sessions per week and each session is between 30 and 50 minutes and with increasing load. Each training session consists of three parts: warm-up, main training body and cool-down. Exercises start in the first week with an intensity of 40% of the maximum heart rate and finally reach 70% of the maximum heart rate in the twelfth week. Maximum heart rate measurement is evaluated using the formula (220-Sen). Also, the assessment of the heart rate of exercise using a polar hourly heart rate monitor. Intervention 2: Intervention group: Combined exercise: Combined group exercises include aerobic and resistance exercises that are performed for 12 weeks, 3 sessions per week and each session between 30 and 60 minutes, with extra load. Each training session consists of three parts: warm-up, main training body and cool-down. The aerobic part of the exercises is performed in the same way as the aerobic exercise group, but with half the time of the aerobic exercise group. The resistance exercises section includes resistance exercises for the upper body with equipment and free weights for the main and large muscle groups of the upper body (head, forearm, chest, armpit, back of the arm, abdomen). Resistance exercises in the first week in 2 sets with 8-12 repetitions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I am completing the information in the future for sure</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maliheh Heydari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan, Najaf Abad, University Boulevard, Najaf Abad Azad University</address>
        <city>Najaf Abad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8514143131۸۵۱</zip>
        <telephone>+98 31 4229 2929</telephone>
        <email>info @ iaun.ac.ir</email>
        <affiliation>Najafabad Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maliheh Heydari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Najafabad branch, Islamic Azad University, Daneshgah Boulevard</address>
        <city>Najaf Abad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8514143131</zip>
        <telephone>+98 31 4229 2929</telephone>
        <email>ict@iaun.ac.ir</email>
        <affiliation>Islamic Azad University, Najaf Abad branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Lower extremity amputation veteran
Written consent to enter the research
Do not have a history of regular sports activities
Have no history of advanced metabolic disease
Do not smoke
Age 45 to 60 years old
Being male</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>60 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Veterans of upper limb amputation and spinal cord amputation
Having a regular sports record
Having advanced metabolic disease
smoking
Infectious diseases such as influenza and covid
Failure to participate in training</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Aerobic exercise: Aerobic group exercises include 12 weeks of exercises, 3 sessions per week and each session is between 30 and 50 minutes and with increasing load. Each training session consists of three parts: warm-up, main training body and cool-down. Exercises start in the first week with an intensity of 40% of the maximum heart rate and finally reach 70% of the maximum heart rate in the twelfth week. Maximum heart rate measurement is evaluated using the formula (220-Sen). Also, the assessment of the heart rate of exercise using a polar hourly heart rate monitor.</i_keyword>
      <i_keyword>Intervention group: Combined exercise: Combined group exercises include aerobic and resistance exercises that are performed for 12 weeks, 3 sessions per week and each session between 30 and 60 minutes, with extra load. Each training session consists of three parts: warm-up, main training body and cool-down. The aerobic part of the exercises is performed in the same way as the aerobic exercise group, but with half the time of the aerobic exercise group. The resistance exercises section includes resistance exercises for the upper body with equipment and free weights for the main and large muscle groups of the upper body (head, forearm, chest, armpit, back of the arm, abdomen). Resistance exercises in the first week in 2 sets with 8-12 repetitions</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Improvement of C-reactive protein level in the blood of lower limb amputees due to exercise.due to exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood tests.</prim_outcome>
      <prim_outcome>Improving the level of interleukin-6 in the blood of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood tests.</prim_outcome>
      <prim_outcome>Improving the level of v-cam in the blood of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood tests.</prim_outcome>
      <prim_outcome>Improving blood ESR levels of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood tests.</prim_outcome>
      <prim_outcome>Improving the fasting blood sugar level of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood tests.</prim_outcome>
      <prim_outcome>Improvement of systolic blood pressure of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training, the individual's resting blood pressure is taken. Method of measurement: Manometer.</prim_outcome>
      <prim_outcome>Improvement of diastolic blood pressure of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training, the individual's resting blood pressure is taken. Method of measurement: Manometer.</prim_outcome>
      <prim_outcome>Improving the red blood cell sedimentation rate of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Lowering blood cholesterol levels of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Reducing the level of low-density lipoprotein cholesterol in the blood of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Increasing the level of high-density lipoprotein cholesterol in the blood of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Reducing blood triglyceride levels of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Improvement of blood alanine aminotransferase levels of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Reduction of aspartate aminotransferase levels in the blood of lower limb amputees due to aerobic and combined exercise. Timepoint: 24 hours before the start of the study and 24 hours after 12 weeks of aerobic and combined training at rest and after 10 hours of overnight fasting, the initial blood sample of 10 cc will be taken from the frontal vein of the subjects. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Improvement of the end-systolic and diastolic inner diameter of the heart due to aerobic and combined exercise. Timepoint: 24 hours before the start of the first exercise and 24 hours after the last exercise, each subject was asked to lie on his left side after choosing the most suitable image of the heart chambers in the resting state, the end-diastolic and systolic diameters (mm) were measured by one-dimensional method. will be. Method of measurement: Echocardiography device.</prim_outcome>
      <prim_outcome>Improvement of left ventricular ejection fraction due to aerobic and combined exercise. Timepoint: 24 hours before the start of the first exercise and 24 hours after the last exercise, each subject was asked to lie on his left side. After selecting the most appropriate image of the heart chambers in the resting state, the variables of the ejection fraction (percentage) are measured by the one-dimensional method. Method of measurement: Echocardiography device.</prim_outcome>
      <prim_outcome>Improving the thickness of the interventricular wall of the heart due to aerobic and combined exercise. Timepoint: 24 hours before the start of the first exercise and 24 hours after the last exercise, each subject was asked to lie on his left side after choosing the most appropriate image of the heart chambers in the resting state, varying the thickness of the interventricular septum (mm) with a one-dimensional measurement method. Method of measurement: Echocardiography device.</prim_outcome>
      <prim_outcome>Improving the thickness of the posterior wall of the left ventricle of the heart as a result of aerobic and combined exercise. Timepoint: 24 hours before the start of the first exercise and 24 hours after the last exercise, each subject was asked to lie on his left side after selecting the most suitable image of the heart chambers in the resting state, varying the thickness of the posterior wall of the left ventricle (mm) with a one-dimensional method. will be measured. Method of measurement: Echocardiography device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Najaf Abadَ Islamic Azad  University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-09-09</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Najaf Abad branch</contact_name>
        <contact_address>Arghavan Street Najafabad Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
